Author | Jeffrey R. Infante, MD | OncLive

Author | Jeffrey R. Infante, MD

Articles

Dr. Infante on AM0010 in Patients With RCC

May 11, 2016

Video

Jeff R. Infante, MD, director, Drug Development Program, Sarah Cannon Research Institute, discusses a phase I study of the novel immunotherapy agent AM0010 and its early promise in patients with renal cell carcinoma.

Dr. Infante on Avelumab's Potential in Ovarian Cancer

July 22, 2015

Video

Jeffrey R. Infante, MD, director, Drug Development Program, Sarah Cannon Research Institute, discusses the potential impact avelumab could have on the treatment of patients with ovarian cancer.

Dr. Infante on the Next Step in Melanoma Research

June 23, 2011

Video

Dr. Jeffrey Infante from Sarah Cannon Research Institute on the Next Step in Melanoma Research

Dr. Infante on the Future of BRAF Inhibitors in Melanoma

June 08, 2011

Video

Dr. Infante from Sarah Cannon Research Institute on the Future of BRAF Inhibitors in Melanoma

x